The Optimal Timing of Hepatitis C Therapy in Transplant Eligible Patients With Child B and C Cirrhosis: A Cost-Effectiveness Analysis

被引：0
|
作者：
Tapper, Elliot B.
Hughes, Michael
Buti, Maria
Dufour, Jean-Francois
Flamm, Steven
Curry, Michael
Afdhal, Nezam H.
机构：
来源：
GASTROENTEROLOGY | 2016年 / 150卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(16)33920-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1663
引用
收藏
页码：S1161 / S1161
页数：1
相关论文
共 50 条
  • [31] Cost-Effectiveness Analysis of Triple Therapy with Protease Inhibitors in Treatment-Naive Hepatitis C Patients
    Antonio Blázquez-Pérez
    Ramón San Miguel
    Javier Mar
    PharmacoEconomics, 2013, 31 : 919 - 931
  • [32] USE OF PEGINTERFERON ALFA-2B IN CHRONIC HEPATITIS C PATIENTS FAILING PRIOR THERAPY: A COST-EFFECTIVENESS ANALYSIS
    O'Sullivan, A. K.
    Buti, M.
    Delong, K.
    Prasad, M.
    Sabater, F. J.
    Esteban, R.
    Weinstein, M. C.
    VALUE IN HEALTH, 2008, 11 (06) : A437 - A437
  • [33] Cost-Effectiveness of Strategies for Treatment Timing for Perinatally Acquired Hepatitis C Virus
    Curtis, Megan Rose
    Epstein, Rachel L.
    Pei, Pamela
    Linas, Benjamin P.
    Ciaranello, Andrea L.
    JAMA PEDIATRICS, 2024, 178 (05) : 489 - 496
  • [34] Cost-effectiveness analysis of treatment timing considering the future entry of lower-cost generics for hepatitis C
    Heath, Katherine
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2018, 10 : 539 - 550
  • [35] Cost-effectiveness analysis of treating transplant-eligible multiple myeloma patients in Macedonia
    Qerimi, Vjollca
    Nestorovska, Aleksandra Kapedanovska
    Sterjev, Zoran
    Genadieva-Stavric, Sonja
    Suturkova, Ljubica
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2018, 10 : 327 - 338
  • [36] COST-EFFECTIVENESS ANALYSIS OF HEPATOCELLULAR CARCINOMA SURVEILLANCE IN PATIENTS WITH HEPATITIS C RELATED CIRRHOSIS AFTER SUSTAINED VIROLOGICAL RESPONSE
    Zangneh, H. Farhang
    Wong, W. W.
    Sander, B.
    Bell, C. M.
    Mumtaz, K.
    Kowgier, M.
    Van Der Meer, A. J.
    Cleary, S. P.
    Chan, K.
    Feld, J. J.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S433 - S433
  • [37] TREATMENT IN TRANSPLANT ELIGIBLE MULTIPLE MYELOMA PATIENTS IN MACEDONIA: DEVELOPMENT OF COST-EFFECTIVENESS ANALYSIS
    Qerimi, V
    Kapedanovska-Nestorovska, A.
    Sterjev, Z.
    Genadieva-Stavric, S.
    Suturkova, L.
    VALUE IN HEALTH, 2017, 20 (09) : A435 - A435
  • [38] COST-EFFECTIVENESS OF SOFOSBUVIR AND LEDIPASVIR IN THE TREATMENT OF PATIENTS WITH HEPATITIS C
    Leleu, H.
    Blachier, M.
    Hauvespre, A.
    Pentel, J.
    VALUE IN HEALTH, 2015, 18 (07) : A585 - A585
  • [39] Effectiveness and cost-effectiveness of antiviral treatment initiation in hepatitis C related decompensated cirrhosis in France
    Willmington, C.
    Ganne-Carrie, N.
    Roudot-Thoraval, F.
    Leroy, V.
    Fontaine, H.
    Canva-Delcambre, V.
    Larrey, D.
    Pol, S.
    Mathurin, P.
    Yazdanpanah, Y.
    Deuffic-Burban, S.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S414 - S415
  • [40] Cost-effectiveness analysis of the universal use of hepatitis A vaccine in patients with chronic hepatitis C.
    Icaza, ME
    Cross, E
    Castillo, C
    Lisker, M
    Kershenobich, D
    Vargas-Vorackova, F
    GASTROENTEROLOGY, 2000, 118 (04) : A679 - A679
12345